For the quarter ended September 2026, Globe Life (GL) reported revenue of $1.61 billion, up 5.9% over the same period last year. EPS came in at $4.84, compared to $4.81 in the year-ago quarter.
The reported revenue represents a surprise of -0.03% over the Zacks Consensus Estimate of $1.61 billion. With the consensus EPS estimate being $4.87, the EPS surprise was -0.62%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Globe Life performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Total premium: $1.31 billion versus $1.31 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change. Revenue- Net investment income: $295.9 million compared to the $297.08 million average estimate based on four analysts. The reported number represents a change of +3.5% year over year. Life Underwriting Margin- Liberty National: $51 million versus the three-analyst average estimate of $54.75 million. The reported number represents a year-over-year change of -27.4%. Life Underwriting Margin- Other: $25.65 million versus the three-analyst average estimate of $33.93 million. The reported number represents a year-over-year change of -29.6%. Life Underwriting Margin- Direct to Consumer: $113.06 million versus $110.35 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -0.6% change. Revenue- Health premium- Family Heritage: $128.63 million versus the three-analyst average estimate of $129.35 million. The reported number represents a year-over-year change of +8.4%. Life Underwriting Margin- American Income: $268.46 million compared to the $253.53 million average estimate based on three analysts. The reported number represents a change of +2.8% year over year. Revenue- Health premium- Direct to Consumer: $20.84 million compared to the $20.87 million average estimate based on three analysts. The reported number represents a change of +8.6% year over year. Revenue- Health premium- American Income: $31.49 million versus $32.31 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -0.6% change. Revenue- Health premium- Liberty National: $46.56 million versus $49.44 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.5% change. Revenue- Health Premium- United American: $219.34 million versus the three-analyst average estimate of $211.78 million. The reported number represents a year-over-year change of +29.2%. Revenue- Life premium- Direct to Consumer: $243.08 million compared to the $243.38 million average estimate based on three analysts. The reported number represents a change of -0.7% year over year.View all Key Company Metrics for Globe Life here>>>
Shares of Globe Life have returned +0.2% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Globe Life Inc. (GL): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).